Liquidia Corporation
Status: Publicly traded
Direct answer
Liquidia Corporation is publicly traded on NASDAQ under the ticker LQDA.
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its...
Can you invest in Liquidia Corporation?
Yes. Liquidia Corporation trades publicly on NASDAQ as LQDA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Liquidia Corporation
Detailed equity research is provided by MarketSnap.